Galderma Laboratories, L.P. et al v. Teva Pharmaceuticals USA, Inc.
Plaintiff: Galderma S.A., Nestle Skin Health S.A. and Galderma Laboratories, L.P.
Defendant: Teva Pharmaceuticals USA, Inc.
Case Number: 1:2019cv00351
Filed: February 19, 2019
Court: US District Court for the District of Delaware
Presiding Judge: Richard G Andrews
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. ยง 271
Jury Demanded By: None
Docket Report

This docket was last retrieved on January 30, 2020. A more recent docket listing may be available from PACER.

Date Filed Document Text
April 18, 2019 Filing 10 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan)
April 18, 2019 Filing 9 ANSWER to #1 Complaint, , COUNTERCLAIM against Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A. by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan)
April 12, 2019 Filing 8 STIPULATION TO EXTEND TIME to Respond to the Complaint to April 18, 2019 - filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan)
April 12, 2019 Opinion or Order SO ORDERED, re #8 STIPULATION TO EXTEND TIME to Respond to the Complaint to April 18, 2019 (*Reset Answer Deadlines: Teva Pharmaceuticals USA, Inc. answer due 4/18/2019). Signed by Judge Richard G. Andrews on 4/12/2019. (nms)
March 18, 2019 Filing 7 STIPULATION TO EXTEND TIME to Respond to Complaint to April 12, 2019 - filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen)
March 18, 2019 Opinion or Order SO ORDERED, re #7 STIPULATION TO EXTEND TIME to Respond to Complaint to April 12, 2019 (*Reset Answer Deadlines: Teva Pharmaceuticals USA, Inc. answer due 4/12/2019). Signed by Judge Richard G. Andrews on 3/18/2019. (nms)
February 27, 2019 Filing 6 SUMMONS Returned Executed by Galderma S.A., Galderma Laboratories, L.P., Nestle Skin Health S.A.. Teva Pharmaceuticals USA, Inc. served on 2/27/2019, answer due 3/20/2019. (Tigan, Jeremy)
February 27, 2019 Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (bkb)
February 21, 2019 Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceuticals USA, Inc. on 2/21/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (rwc)
February 19, 2019 Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Galderma General, L.L.C., Corporate Parent Galderma Limited, L.L.C., Corporate Parent Nestle Skin Health U.S., Inc. for Galderma Laboratories, L.P.; Corporate Parent Galderma Pharma S.A. for Galderma S.A. filed by Galderma Laboratories, L.P., Galderma S.A., Nestle Skin Health S.A. (rwc)
February 19, 2019 Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,206,939 B2. (rwc)
February 19, 2019 Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: N/A. Date of Expiration of Patent: 3/13/34. (rwc)
February 19, 2019 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (rwc)
February 19, 2019 Filing 1 COMPLAINT FOR PATENT INFRINGEMENT - filed against Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2573986.) - filed by Galderma S.A., Galderma Laboratories, L.P., Nestle Skin Health S.A. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(rwc)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Galderma Laboratories, L.P. et al v. Teva Pharmaceuticals USA, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Teva Pharmaceuticals USA, Inc.
Represented By: Nathan Roger Hoeschen
Represented By: Karen Elizabeth Keller
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Galderma S.A.
Represented By: Jeremy A. Tigan
Represented By: Jack B. Blumenfeld
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Nestle Skin Health S.A.
Represented By: Jeremy A. Tigan
Represented By: Jack B. Blumenfeld
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Galderma Laboratories, L.P.
Represented By: Jeremy A. Tigan
Represented By: Jack B. Blumenfeld
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?